Patients in the response-guided therapy arm ( D ) with an extended rapid virological response ( eRVR@ : HCV RNA < @ IU/ml during Weeks @-@ ) stopped all therapy at Week @ ; non-eRVR@ patients continued all treatment to Week @ .